• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Taiwan·Healthcare·4102.TWO
Share

Yung Zip Chemical Ind. Co., Ltd. Stocks

NT$ 19.55Last Updated 28.07.2026

Issuer Rating

3/7
Performance

Modest

Risk

Considerable

Recommendation

Sell

Market Cap

NT$ 25.57M

NT$ 19.55
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very weak growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Yung Zip Chemical Ind. Co., Ltd. is a global provider specializing in the manufacture of essential pharmaceutical components. The company supplies active pharmaceutical ingredients (APIs), their intermediate precursors, and various specialty chemicals to markets around the world. Their diverse product portfolio includes a wide array of therapeutic agents addressing conditions such as hypertension, iron overload, inflammation, pain, fever, fungal infections, schizophrenia, blood clotting issues, genital herpes outbreaks, and sleep disorders (hypnotics and sedatives). In addition to these core offerings, Yung Zip also provides pharmaceutical excipients, such as sodium starch glycolate, and offers bespoke research, development, and manufacturing services. The company, established in 1978, is headquartered in Taichung, Taiwan.

Company Valuation

Slightly overvalued
3/7

Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.07.2026 16:55

The FT has learned that TotalEnergies stands to benefit from the easing of EU sanctions on Russian gas

28.07.2026 16:24

Iran and Oman are negotiating the reopening of the Strait of Hormuz. Brent crude is down 2%.

28.07.2026 15:39

Morning in New York: Investors Need New Signals

28.07.2026 15:12

Shares of a small-cap company developing a treatment for vitiligo have skyrocketed. A competitor wants to buy it.

28.07.2026 13:47

An Nvidia employee was detained in Taiwan in connection with a case involving the smuggling of AI chips to China

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026